Assessment of small intestinal damage in patients treated with pelvic radiotherapy

Romano Carratù, Mario Secondulfo, Laura De Magistris, Bruno Daniele, Sandro Pignata, Luciano D'Agostino, Pasquale Frezza, Massimo Elmo, Giustino Silvestro, Francesco Saverio Sasso

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pelvic radiotherapy almost always induces intestinal symptoms. We investigated the radiation-induced damage to the small intestinal mucosa and evaluated its relationship with symptoms, using cellobiose/mannitol permeability test (CE/MA) and plasma postheparin diamine oxidase test (PHD) in 20 patients treated with pelvic radiotherapy. The symptoms developed during radiotherapy were noted. Intestinal permeability significantly (p=0.013) increased from 0.021±0.026 to 0.047±0.055 (mean ± SD) after 15 days of radiotherapy, while it returned to normal values (0.010±0.015) at the end of radiotherapy. PHD values did not change. All patients developed intestinal symptoms. These findings indicate that pelvic radiotherapy induces an early small bowel mucosa damage followed by mucosal adaptation. Acute intestinal symptoms during pelvic radiotherapy may not depend only on small intestinal mucosal damage.

Original languageEnglish
Pages (from-to)635-639
Number of pages5
JournalOncology Reports
Volume5
Issue number3
Publication statusPublished - 1998

Fingerprint

Radiotherapy
Permeability
Amine Oxidase (Copper-Containing)
Cellobiose
Mannitol
Intestinal Mucosa
Reference Values
Mucous Membrane
Radiation

Keywords

  • Acute radiation enteropathy
  • Cellobiose
  • Intestinal permeability
  • Mannitol
  • Pelvic radiotherapy
  • Plasma postheparin diamine oxidase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Carratù, R., Secondulfo, M., De Magistris, L., Daniele, B., Pignata, S., D'Agostino, L., ... Sasso, F. S. (1998). Assessment of small intestinal damage in patients treated with pelvic radiotherapy. Oncology Reports, 5(3), 635-639.

Assessment of small intestinal damage in patients treated with pelvic radiotherapy. / Carratù, Romano; Secondulfo, Mario; De Magistris, Laura; Daniele, Bruno; Pignata, Sandro; D'Agostino, Luciano; Frezza, Pasquale; Elmo, Massimo; Silvestro, Giustino; Sasso, Francesco Saverio.

In: Oncology Reports, Vol. 5, No. 3, 1998, p. 635-639.

Research output: Contribution to journalArticle

Carratù, R, Secondulfo, M, De Magistris, L, Daniele, B, Pignata, S, D'Agostino, L, Frezza, P, Elmo, M, Silvestro, G & Sasso, FS 1998, 'Assessment of small intestinal damage in patients treated with pelvic radiotherapy', Oncology Reports, vol. 5, no. 3, pp. 635-639.
Carratù R, Secondulfo M, De Magistris L, Daniele B, Pignata S, D'Agostino L et al. Assessment of small intestinal damage in patients treated with pelvic radiotherapy. Oncology Reports. 1998;5(3):635-639.
Carratù, Romano ; Secondulfo, Mario ; De Magistris, Laura ; Daniele, Bruno ; Pignata, Sandro ; D'Agostino, Luciano ; Frezza, Pasquale ; Elmo, Massimo ; Silvestro, Giustino ; Sasso, Francesco Saverio. / Assessment of small intestinal damage in patients treated with pelvic radiotherapy. In: Oncology Reports. 1998 ; Vol. 5, No. 3. pp. 635-639.
@article{67c5291b139842778a741e962a9a3e35,
title = "Assessment of small intestinal damage in patients treated with pelvic radiotherapy",
abstract = "Pelvic radiotherapy almost always induces intestinal symptoms. We investigated the radiation-induced damage to the small intestinal mucosa and evaluated its relationship with symptoms, using cellobiose/mannitol permeability test (CE/MA) and plasma postheparin diamine oxidase test (PHD) in 20 patients treated with pelvic radiotherapy. The symptoms developed during radiotherapy were noted. Intestinal permeability significantly (p=0.013) increased from 0.021±0.026 to 0.047±0.055 (mean ± SD) after 15 days of radiotherapy, while it returned to normal values (0.010±0.015) at the end of radiotherapy. PHD values did not change. All patients developed intestinal symptoms. These findings indicate that pelvic radiotherapy induces an early small bowel mucosa damage followed by mucosal adaptation. Acute intestinal symptoms during pelvic radiotherapy may not depend only on small intestinal mucosal damage.",
keywords = "Acute radiation enteropathy, Cellobiose, Intestinal permeability, Mannitol, Pelvic radiotherapy, Plasma postheparin diamine oxidase",
author = "Romano Carrat{\`u} and Mario Secondulfo and {De Magistris}, Laura and Bruno Daniele and Sandro Pignata and Luciano D'Agostino and Pasquale Frezza and Massimo Elmo and Giustino Silvestro and Sasso, {Francesco Saverio}",
year = "1998",
language = "English",
volume = "5",
pages = "635--639",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Assessment of small intestinal damage in patients treated with pelvic radiotherapy

AU - Carratù, Romano

AU - Secondulfo, Mario

AU - De Magistris, Laura

AU - Daniele, Bruno

AU - Pignata, Sandro

AU - D'Agostino, Luciano

AU - Frezza, Pasquale

AU - Elmo, Massimo

AU - Silvestro, Giustino

AU - Sasso, Francesco Saverio

PY - 1998

Y1 - 1998

N2 - Pelvic radiotherapy almost always induces intestinal symptoms. We investigated the radiation-induced damage to the small intestinal mucosa and evaluated its relationship with symptoms, using cellobiose/mannitol permeability test (CE/MA) and plasma postheparin diamine oxidase test (PHD) in 20 patients treated with pelvic radiotherapy. The symptoms developed during radiotherapy were noted. Intestinal permeability significantly (p=0.013) increased from 0.021±0.026 to 0.047±0.055 (mean ± SD) after 15 days of radiotherapy, while it returned to normal values (0.010±0.015) at the end of radiotherapy. PHD values did not change. All patients developed intestinal symptoms. These findings indicate that pelvic radiotherapy induces an early small bowel mucosa damage followed by mucosal adaptation. Acute intestinal symptoms during pelvic radiotherapy may not depend only on small intestinal mucosal damage.

AB - Pelvic radiotherapy almost always induces intestinal symptoms. We investigated the radiation-induced damage to the small intestinal mucosa and evaluated its relationship with symptoms, using cellobiose/mannitol permeability test (CE/MA) and plasma postheparin diamine oxidase test (PHD) in 20 patients treated with pelvic radiotherapy. The symptoms developed during radiotherapy were noted. Intestinal permeability significantly (p=0.013) increased from 0.021±0.026 to 0.047±0.055 (mean ± SD) after 15 days of radiotherapy, while it returned to normal values (0.010±0.015) at the end of radiotherapy. PHD values did not change. All patients developed intestinal symptoms. These findings indicate that pelvic radiotherapy induces an early small bowel mucosa damage followed by mucosal adaptation. Acute intestinal symptoms during pelvic radiotherapy may not depend only on small intestinal mucosal damage.

KW - Acute radiation enteropathy

KW - Cellobiose

KW - Intestinal permeability

KW - Mannitol

KW - Pelvic radiotherapy

KW - Plasma postheparin diamine oxidase

UR - http://www.scopus.com/inward/record.url?scp=13144293112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144293112&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 635

EP - 639

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -